Patents by Inventor Edgar H. Ulm

Edgar H. Ulm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL FORMULATIONS AND METHODS FOR PRODUCING AND USING SAME
    Publication number: 20100063020
    Abstract: Oral pharmaceutical formulations and methods of producing and using the same are described and claimed. The formulations are dispersions of phospholipids and one or more pharmacologically active compounds, In preferred embodiments, the pharmaceutically active compounds are ansamycins, pharmaceutically acceptable salts, or prodrugs thereof.
    Type: Application
    Filed: September 4, 2009
    Publication date: March 11, 2010
    Inventors: Robert K. Mansfield, Edgar H. Ulm, Gregg A. Timony
  • PHOSPHOLIPID-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR PRODUCING AND USING SAME
    Publication number: 20090238880
    Abstract: Pharmaceutical formulations and methods of producing and using the same are described and claimed. The formulations are dispersions of phospholipids and one or more pharmacologically active compounds, pharmaceutically acceptable salts thereof, or prodrugs thereof. In specific embodiments, the pharmaceutically active compounds are ansamycins and the overall formulation is substantially devoid of medium and long chain triglycerides.
    Type: Application
    Filed: February 12, 2009
    Publication date: September 24, 2009
    Inventors: Edgar H. Ulm, Robert K. Mansfield, Gregg A. Timony, Marcus F. Boehm
  • 7-chloro-5,6-di hydro-3-(5-(1,2-dihydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo -4H-imidazo[1,5A][1,4]benzodiazepine
    Patent number: 4939139
    Abstract: A metabolite of the known anxiolytic agent, 7-chloro-5,6-dihydro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4 H-i midazo[1,5a][1,4]benzodiazepine is a 1,2-dihydroxy derivative of the isopropyl moiety and is itself an anxiolytic agent of greater activity than its substrate.
    Type: Grant
    Filed: July 26, 1989
    Date of Patent: July 3, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Jiunn H. Lin, Harri G. Ramjit, Steven M. Pitzenberger, Edgar H. Ulm
  • 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isoprop yl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazep ine
    Patent number: 4904654
    Abstract: A metabolite of the known anxiolytic agent, 7-chloro-5,6-dihydro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4 H- imidazo[1,5a][1,4]benzodiazepine is a 2-hydroxy derivative of the isopropyl moiety and is itself an anxiolytic agent.
    Type: Grant
    Filed: July 26, 1989
    Date of Patent: February 27, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Jiunn H. Lin, Steven M. Pitzenberger, Harri G. Ramjit, Edgar H. Ulm